Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,071 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic ability of maximum blink interval together with Japanese version of Ocular Surface Disease Index score for dry eye disease.
Hirosawa K, Inomata T, Sung J, Nakamura M, Okumura Y, Midorikawa-Inomata A, Miura M, Fujio K, Akasaki Y, Fujimoto K, Zhu J, Eguchi A, Nagino K, Kuwahara M, Shokirova H, Yanagawa A, Murakami A. Hirosawa K, et al. Among authors: fujimoto k. Sci Rep. 2020 Oct 22;10(1):18106. doi: 10.1038/s41598-020-75193-4. Sci Rep. 2020. PMID: 33093551 Free PMC article.
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation.
Shokirova H, Inomata T, Saitoh T, Zhu J, Fujio K, Okumura Y, Yanagawa A, Fujimoto K, Sung J, Eguchi A, Miura M, Nagino K, Hirosawa K, Kuwahara M, Akasaki Y, Nagase H, Murakami A. Shokirova H, et al. Among authors: fujimoto k. Sci Rep. 2021 Apr 21;11(1):8647. doi: 10.1038/s41598-021-88118-6. Sci Rep. 2021. PMID: 33883646 Free PMC article.
Anti-CD80/86 antibodies inhibit inflammatory reaction and improve graft survival in a high-risk murine corneal transplantation rejection model.
Zhu J, Inomata T, Nakamura M, Fujimoto K, Akasaki Y, Fujio K, Yanagawa A, Uchida K, Sung J, Negishi N, Nagino K, Okumura Y, Miura M, Shokirova H, Kuwahara M, Hirosawa K, Midorikawa-Inomata A, Eguchi A, Huang T, Yagita H, Habu S, Okumura K, Murakami A. Zhu J, et al. Among authors: fujimoto k. Sci Rep. 2022 Mar 22;12(1):4853. doi: 10.1038/s41598-022-08949-9. Sci Rep. 2022. PMID: 35318419 Free PMC article.
Prevalence and characteristics of dry eye disease in Parkinson's disease: a systematic review and meta-analysis.
Nagino K, Sung J, Oyama G, Hayano M, Hattori N, Okumura Y, Fujio K, Akasaki Y, Huang T, Midorikawa-Inomata A, Fujimoto K, Eguchi A, Hurramhon S, Miura M, Ohno M, Hirosawa K, Morooka Y, Murakami A, Kobayashi H, Inomata T. Nagino K, et al. Among authors: fujimoto k. Sci Rep. 2022 Nov 1;12(1):18348. doi: 10.1038/s41598-022-22037-y. Sci Rep. 2022. PMID: 36319814 Free PMC article.
Symptom-based stratification algorithm for heterogeneous symptoms of dry eye disease: a feasibility study.
Nagino K, Inomata T, Nakamura M, Sung J, Midorikawa-Inomata A, Iwagami M, Fujio K, Akasaki Y, Okumura Y, Huang T, Fujimoto K, Eguchi A, Miura M, Hurramhon S, Zhu J, Ohno M, Hirosawa K, Morooka Y, Dana R, Murakami A, Kobayashi H. Nagino K, et al. Among authors: fujimoto k. Eye (Lond). 2023 Nov;37(16):3484-3491. doi: 10.1038/s41433-023-02538-4. Epub 2023 Apr 15. Eye (Lond). 2023. PMID: 37061620
Clinical utility of maximum blink interval measured by smartphone application DryEyeRhythm to support dry eye disease diagnosis.
Fujio K, Nagino K, Huang T, Sung J, Akasaki Y, Okumura Y, Midorikawa-Inomata A, Fujimoto K, Eguchi A, Miura M, Hurramhon S, Yee A, Hirosawa K, Ohno M, Morooka Y, Murakami A, Kobayashi H, Inomata T. Fujio K, et al. Among authors: fujimoto k. Sci Rep. 2023 Aug 21;13(1):13583. doi: 10.1038/s41598-023-40968-y. Sci Rep. 2023. PMID: 37604900 Free PMC article.
4,071 results